Danielle De Merieux, MD | |
3541 Washington Blvd Ste 110, Arbutus, MD 21227-1623 | |
(443) 543-9914 | |
Not Available |
Full Name | Danielle De Merieux |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 3541 Washington Blvd Ste 110, Arbutus, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316366925 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 289716 (New York) | Secondary |
207R00000X | Internal Medicine | D96926 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Danielle De Merieux, MD Po Box 22389, Pmb 82739, Nashville, TN 37202 Ph: (866) 315-2626 | Danielle De Merieux, MD 3541 Washington Blvd Ste 110, Arbutus, MD 21227-1623 Ph: (443) 543-9914 |
News Archive
Autism Speaks' not-for-profit affiliate Delivering Scientific Innovation for Autism has announced new funding for clinical testing of a cognitive video game designed to improve executive function skills in children and adolescents with autism.
PerFix-Expose1 and PerFix-nc1, innovative new reagent kits for intracellular staining from Beckman Coulter Life Sciences, minimize sample manipulation for a streamlined workflow that delivers high quality results. Developed for use on Beckman Coulter's Gallios1 and Navios2 series flow cytometers and compatible with all Beckman Coulter Life Sciences' fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell.
Rockefeller and Company - a leading global wealth management firm serving high-net-worth individuals, families, trusts, foundations and endowments - today released "The Investment Opportunities in Healthcare Reform," a white paper discussing the compelling investment opportunities related to the U.S. healthcare reform initiative.
RaySearch Laboratories AB has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation in Australia and New Zealand from April 1, 2014.
› Verified 1 days ago